Published in Arterioscler Thromb Vasc Biol on October 01, 1997
Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics. Pharmacol Ther (2009) 1.66
Endothelial dysfunction: the early predictor of atherosclerosis. Cardiovasc J Afr (2012) 1.55
Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype. Am J Pathol (2002) 1.43
Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. J Clin Invest (1999) 1.42
VCAM-1 signals during lymphocyte migration: role of reactive oxygen species. Mol Immunol (2002) 1.25
Subcellular and cellular locations of nitric oxide synthase isoforms as determinants of health and disease. Free Radic Biol Med (2010) 1.25
Regulation of cardiac remodeling by nitric oxide: focus on cardiac myocyte hypertrophy and apoptosis. Heart Fail Rev (2002) 1.11
Exercise training enhanced myocardial endothelial nitric oxide synthase (eNOS) function in diabetic Goto-Kakizaki (GK) rats. Cardiovasc Diabetol (2008) 1.03
Adrenoreceptors and nitric oxide in the cardiovascular system. Front Physiol (2013) 0.95
Nitric oxide in the cardiovascular system: a simple molecule with complex actions. Cardiovasc J Afr (2009) 0.85
Haplotypes of NOS3 gene polymorphisms in dilated cardiomyopathy. PLoS One (2013) 0.85
Direct myocardial anti-ischaemic effect of GTN in both nitrate-tolerant and nontolerant rats: a cyclic GMP-independent activation of KATP. Br J Pharmacol (1999) 0.81
Inhibition of nitric oxide synthesis improves left ventricular contractility in neonatal pigs late after cardiopulmonary bypass. Heart (1999) 0.80
Upregulation of cardiac NO/NOS system during short-term hypoxia and the subsequent reoxygenation period. Eur J Histochem (2011) 0.79
Role of nitric oxide in the pathophysiology of heart failure. Heart Fail Rev (2003) 0.78
Nitric oxide, cell death, and heart failure. Heart Fail Rev (2002) 0.78
Intracellular regulation of matrix metalloproteinase-2 activity: new strategies in treatment and protection of heart subjected to oxidative stress. Scientifica (Cairo) (2013) 0.77
Response of cardiac endothelial nitric oxide synthase to plasma viscosity modulation in acute isovolemic hemodilution. Asian J Transfus Sci (2014) 0.75
Treatment with TNF-alpha or bacterial lipopolysaccharide attenuates endocardial endothelial cell-mediated stimulation of cardiac fibroblasts. J Biomed Sci (2009) 0.75
The role of nitric oxide in Doxorubicin-induced cardiotoxicity: experimental study. Turk J Haematol (2014) 0.75
Nitric oxide homeostasis as a target for drug additives to cardioplegia. Br J Pharmacol (2007) 0.75
Vascular Endothelial Growth Factor Increases Endothelial Nitric Oxide Synthase Transcription In Huvec Cells. Webmedcentral (2010) 0.75
Subthreshold nitric oxide synthase inhibition improves synergistic effects of subthreshold MMP-2/MLCK-mediated cardiomyocyte protection from hypoxic injury. J Cell Mol Med (2016) 0.75
GRK2 as negative modulator of NO bioavailability: Implications for cardiovascular disease. Cell Signal (2017) 0.75
Hyperuricemia in primary and renal hypertension. N Engl J Med (1966) 2.22
L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice. Circulation (1997) 1.83
ANGIOTENSIN II, NOREPINEPHRINE, AND RENAL TRANSPORT OF ELECTROLYTES AND WATER IN NORMAL MAN AND IN CIRRHOSIS WITH ASCITES. J Clin Invest (1963) 1.82
Respiratory adjustment to chronic metabolic alkalosis in man. J Clin Invest (1968) 1.70
The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation. Medicine (Baltimore) (1974) 1.62
Relation between potassium balance and aldosterone secretion in normal subjects and in patients with hypertensive or renal tubular disease. J Clin Invest (1966) 1.51
Physiologic and clincical observations on furosemide and ethacrynic acid. Ann N Y Acad Sci (1966) 1.50
Furosemide. A clinical evaluation of its diuretic action. Circulation (1966) 1.40
Regulation of adenylyl cyclase by protein kinase A. J Biol Chem (1995) 1.36
The kidney in heart failure. N Engl J Med (1977) 1.34
THE NATURE OF THE ACTION OF INTRAVENOUS ALDOSTERONE: EVIDENCE FOR A ROLE OF THE HORMONE IN URINARY DILUTION. J Clin Invest (1961) 1.33
Induction of myocardial nitric oxide synthase by cardiac allograft rejection. J Clin Invest (1994) 1.13
Endothelial cell leukotriene C4 synthesis results from intercellular transfer of leukotriene A4 synthesized by polymorphonuclear leukocytes. J Biol Chem (1986) 1.13
Juxtaglomerular cell hyperplasia and secondary hyperaldosteronism (Bartter's syndrome): a re-evaluation of the pathophysiology. Medicine (Baltimore) (1968) 1.12
Stimulation of arterial endothelial cell prostacyclin synthesis by high density lipoproteins. J Biol Chem (1982) 1.11
Cardiac preservation is enhanced in a heterotopic rat transplant model by supplementing the nitric oxide pathway. J Clin Invest (1994) 1.10
A weighted least-squares technique for the analysis of kinetic data and its application to the study of renal xenon washout in dogs and man. Circ Res (1973) 1.09
The influence of hypertonic saline infusions upon the fractional reabsorption of urate and other ions in normal and hypertensive man. Circulation (1970) 1.08
Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes. Arterioscler Thromb Vasc Biol (2000) 1.07
The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta. J Clin Invest (1995) 1.05
Regulation of cardiac beta-adrenergic response by nitric oxide. Cardiovasc Res (1999) 1.05
Comparison of single-dose and double-dose thallium-201 myocardial perfusion scintigraphy for the detection of coronary artery disease and prior myocardial infarction. Circulation (1978) 0.98
Participation of the prostaglandins in the control of renal blood flow during acute reduction of cardiac output in the dog. J Clin Invest (1981) 0.98
Is elevated plasma renin activity of prognostic importance in progressive systemic sclerosis? Arch Intern Med (1977) 0.97
Apoptosis of cardiac myocytes during cardiac allograft rejection. Relation to induction of nitric oxide synthase. Circulation (1996) 0.97
Skin capillary blood flow in scleroderma. J Clin Invest (1971) 0.97
Measurement of regional myocardial perfusion in man with 133 xenon and a scintillation camera. J Clin Invest (1972) 0.96
Absolute quantitation of coronary steal induced by intravenous dipyridamole. J Am Coll Cardiol (2001) 0.96
Influence of thoracic caval occlusion on intrarenal blood flow distribution and sodium excretion. Am J Physiol (1971) 0.94
Volume ejected in early systole. A sensitive index of left ventricular performance in coronary artery disease. Circulation (1975) 0.94
Myocardial perfusion imaging with technetium-99m SQ30217: comparison with thallium-201 and coronary anatomy. J Nucl Med (1989) 0.94
Reduced left ventricular myocardial blood flow per unit mass in aortic stenosis. Circulation (1978) 0.94
Apoptosis and increased expression of inducible nitric oxide synthase in human allograft rejection. Transplantation (1998) 0.92
Single dose myocardial perfusion imaging with thallium-201: application in patients with nondiagnostic electrocardiographic stress tests. Am J Cardiol (1979) 0.90
Stimulation of vascular smooth muscle cell prostacyclin and prostaglandin E2 synthesis by plasma high and low density lipoproteins. Circ Res (1984) 0.90
Modulation of angiotensin II coronary vasoconstriction by cardiac prostaglandin synthesis. Am J Physiol (1980) 0.89
Neural and humoral influences on intrarenal blood flow distribution during thoracic caval occlusion. Am J Physiol (1971) 0.89
Measurement of regional myocardial blood flow in man: description and critique of the method using xenon-133 and a scintillation camera. Am J Cardiol (1975) 0.88
Lactic Acid Metabolism in Hypertensive Patients. Science (1965) 0.88
Left ventricular mechanical efficiency in coronary artery disease. J Am Coll Cardiol (1986) 0.87
Modulation by prostaglandins of the renal vascular action of arginine vasopressin. Prostaglandins (1982) 0.87
Prostaglandins in congestive heart failure and the effects of nonsteroidal anti-inflammatory drugs. Am J Med (1986) 0.87
Acute reoxygenation injury in the isolated rat heart: role of resident cardiac mast cells. Circ Res (1988) 0.87
Measurement of infarct size and percentage myocardium infarcted in a dog preparation with single photon-emission computed tomography, thallium-201, and indium 111-monoclonal antimyosin Fab. Circulation (1987) 0.86
The effect of altered sodium balance upon renal vascular reactivity to angiotensin II and norepinephrine in the dog. Mechanism of variation in angiotensin responses. J Clin Invest (1978) 0.86
Myocardial blood flow in congestive and hypertrophic cardiomyopathy: relationship to peak wall stress and mean velocity of circumferential fiber shortening. Circulation (1976) 0.86
Sequence-independent inhibition of in vitro vascular smooth muscle cell proliferation, migration, and in vivo neointimal formation by phosphorothioate oligodeoxynucleotides. J Clin Invest (1996) 0.86
Use of thionitrobenzoic acid to characterize the stability of nitric oxide in aqueous solutions and in porcine aortic endothelial cell suspensions. Anal Biochem (1990) 0.85
Renin and aldosterone secretion in man as influenced by changes in electrolyte balance and blood volume. Circ Res (1970) 0.85
Acute cardiac allograft rejection in nitric oxide synthase-2(-/-) and nitric oxide synthase-2(+/+) mice: effects of cellular chimeras on myocardial inflammation and cardiomyocyte damage and apoptosis. Circulation (2001) 0.85
Improved exercise ejection fraction with long-term prazosin therapy in patients with heart failure. Am J Med (1980) 0.85
Enrichment of endothelial cell arachidonate by lipid transfer from high density lipoproteins: relationship to prostaglandin I2 synthesis. J Lipid Res (1985) 0.84
Basal norepinephrine overflow into the renal vein: effect of renal nerve stimulation. Am J Physiol (1980) 0.84
Imaging of cardiac allograft rejection in dogs using indium-111 monoclonal antimyosin Fab. J Am Coll Cardiol (1987) 0.84
Inducible nitric oxide synthase expression in smooth muscle cells and macrophages of human transplant coronary artery disease. Circulation (1998) 0.84
Regional myocardial blood flow in patients with residual anterior and inferior transmural infarction. Circulation (1973) 0.84
The kidney in scleroderma. Nephron (1977) 0.84
Visual assessment of regional myocardial perfusion utilizing radioactive xenon and scintillation photography. Circulation (1969) 0.84
Fibrinopeptide A, platelet factor 4, and beta-thromboglobulin levels in coronary heart disease. Blood (1982) 0.83
Regional myocardial perfusion rates in patient with coronary artery disease. J Clin Invest (1972) 0.83
Nitric oxide triggers programmed cell death (apoptosis) of adult rat ventricular myocytes in culture. Am J Physiol (1999) 0.83
Ethacrynate-induced depression of respiration in transport systems and kidney mitochondria. Am J Physiol (1973) 0.82
Reduced lymphocyte stimulatory guanine nucleotide regulatory protein and beta-adrenergic receptors in congestive heart failure and reversal with angiotensin converting enzyme inhibitor therapy. Circulation (1988) 0.81
The effect of captopril on renal, coronary, and systemic hemodynamics in patients with severe congestive heart failure. Am Heart J (1982) 0.81
Upregulation of COX-2 during cardiac allograft rejection. Circulation (2000) 0.81
Increased renal secretion of norepinephrine and prostaglandin E2 during sodium depletion in the dog. J Clin Invest (1980) 0.81
Effects of immunosuppressive therapy on expression of inducible nitric oxide synthase (iNOS) during cardiac allograft rejection. Int J Cardiol (1995) 0.81
Renal vasodilation by converting enzyme inhibition. Role of renal prostaglandins. Hypertension (1983) 0.81
Indirect action of angiotensin infusion to inhibit renal tubular sodium reabsorption in dogs. Am J Physiol (1966) 0.81
Intrarenal blood flow in congestive heart failure. Circulation (1973) 0.80
Leukotriene biosynthesis by canine and human coronary arteries. J Pharmacol Exp Ther (1987) 0.80
Sodium nuclear magnetic resonance imaging of myocardial tissue of dogs after coronary artery occlusion and reperfusion. J Am Coll Cardiol (1986) 0.80
Effects of five per cent dextros-water infusions in normal and hypertensive man. Evidence for increased proximal and distal tubular sodium rejection by hypertensive patients and its relation to renal hemodynamics. Circulation (1968) 0.80
Comparison of regional myocardial blood flow measurements with 133Xe and radioactive microspheres in dogs with coronary artery constrictions. Cardiovasc Res (1979) 0.80
Inhibition of inducible nitric oxide synthase in macrophages by oxidized low-density lipoproteins. Circ Res (1994) 0.80
Relation between survival and development of coronary artery disease and anti-HLA antibodies after cardiac transplantation. Circulation (1989) 0.80
Increased immunoreactive endothelin-1 in human transplant coronary artery disease. Circulation (1996) 0.79
Effect of left ventricular hypertrophy on myocardial blood flow and ventricular performance in systemic hypertension. Circulation (1980) 0.79
Evaluation of triple-quantum-filtered 23Na NMR in monitoring of Intracellular Na content in the perfused rat heart: comparison of intra- and extracellular transverse relaxation and spectral amplitudes. Magn Reson Med (1996) 0.79
Renal vascular and excretory responses to prostaglandin endoperoxides in the dog. Am J Physiol (1979) 0.79
Ethacrynic acid and furosemide: renal pharmacology and clinical use. Prog Cardiovasc Dis (1969) 0.79
Regional myocardial perfusion during atrial pacing in patients with coronary artery disease. Circulation (1976) 0.79
Effect of elevations of coronary artery partial pressure of carbon dioxide (PCO2) on coronary blood flow. J Am Coll Cardiol (1986) 0.79
The distribution of urate in human and primate kidney. Proc Soc Exp Biol Med (1968) 0.79
Vascular smooth muscle cell leukotriene C4 synthesis: requirement for transcellular leukotriene A4 metabolism. Biochim Biophys Acta (1987) 0.79
Ultrasonic angioplasty in totally occluded peripheral arteries. Initial clinical, histological, and angiographic results. Circulation (1991) 0.79
Oxidized low density lipoproteins alter macrophage lipid uptake, apoptosis, viability and nitric oxide synthesis. J Nutr (1996) 0.78
Plasma levels of tissue plasminogen activator and plasminogen activator inhibitor-1 are correlated with the presence of transplant coronary artery disease in cardiac transplant recipients. Am J Cardiol (1997) 0.78
Detection of an extracellular contribution from a second-rank tensor to the double-quantum-filtered 23Na NMR spectrum in the isolated perfused rat heart. J Magn Reson B (1995) 0.78
Bayesian analysis using Fourier transforms of thallium-201 scintiscans to predict the presence of coronary artery disease. Am J Cardiol (1984) 0.78
Effects of propranolol and timolol on left ventricular volumes during exercise in patients with coronary artery disease. J Am Coll Cardiol (1984) 0.78
Multiplicity in type V adenylylcyclase: type V-a and type V-b. Mol Cell Endocrinol (1995) 0.77
Effect of diuretics on electrolyte and lactate gradients in dog kidney. J Lab Clin Med (1968) 0.77
Immunohistochemical demonstration of 15-lipoxygenase in transplant coronary artery disease. Arterioscler Thromb Vasc Biol (1995) 0.77
Analysis of CD154 and CD40 expression in native coronary atherosclerosis and transplant associated coronary artery disease. Virchows Arch (2000) 0.77
T cell lymphokines modulate bFGF-induced smooth muscle cell fibrinolysis and migration. Am J Physiol (1997) 0.77
Right ventricular ejection fraction during exercise in patients with coronary artery disease. Circulation (1979) 0.77
Discriminant function analysis using thallium-20 1 scintiscans and exercise stress test variables to predict the presence and extent of cornary artery disease. Am J Cardiol (1982) 0.77
Measurement of regional cerebral blood flow with 133xenon and a multiple-crystal scintillation camera. Stroke (1974) 0.77